Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02272998
Title Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sameek Roychowdhury
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Ponatinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Completed Ann Arbor Michigan 48109 United States Details
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field